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demonstrated enhanced entry into
renal epithelial cells (10). In our stud-
ies, we did not find enhanced virus
replication in the respiratory tract of
vaccinated mice upon SARS-CoV
challenge. However, since mice are a
model of SARS-CoV infection but
not disease, the issue of disease
enhancement will have to be careful-
ly evaluated if and when an appropri-
ate animal model in which this phe-
nomenon can be demonstrated
becomes available.
In summary, an inactivated SARS-
CoV vaccine, produced with a tech-
nology that has a safety record estab-
lished by immunizing hundreds of
millions of persons, protects mice
from challenge with SARS-CoV. The
vaccine adjuvanted with MF59 elicits
neutralizing antibodies (titer 1:91)
after only 2 doses. We conclude that
the vaccine described here has desir-
able properties, and our data support
further development and plans for
clinical trials.
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Echinococcosis,
Ningxia, China 
To the Editor: Ningxia is the
smallest provincial autonomous
region on the Loess Plateau in central
China, with a population of ≈5.5 mil-
lion persons composed of 35 ethnic
and various religious groups. The nat-
ural environmental conditions and
socioreligious ethnic status in
Ningxia, particularly the southern
region, are conducive to sheep farm-
ing, an important part of the agricul-
tural economy. Both cystic echinococ-
cosis (CE) and alveolar echinococco-
sis (AE) (1) are endemic in the north-
west part of China; high prevalences
have been reported in several
provinces (1), including Gansu (2,3)
and the Xinjiang Uigur Autonomous
Region (4). Little information is avail-
able about the extent of human
echinococcosis in Ningxia; this is the
first report of a provincial investiga-
tion for both human CE and AE there.
We conducted a retrospective sur-
vey of clinical records from 7 local
county hospitals and 4 other hospitals
in Yinchuan to determine the epidemi-
ology of human echinococcosis in
southern Ningxia. All surgical and
clinical records were checked, and
diagnoses were confirmed based on
imaging, surgical reports, and
histopathologic reports. Data concern-
ing age, sex, domicile, ethnicity, occu-
pation, year of diagnosis, cyst or
lesion numbers and anatomical loca-
tion, type and duration of
anthelminthic treatment (if given),
and the nature and number of surger-
ies performed for echinococcosis
were recorded for each confirmed CE
and AE patient.
From 1985 to 2002, a total of
2,216 cases of echinococcosis were
recorded, most of which were due to
CE (96%). The incidence of com-
bined CE and AE from 1994 to 2001
was 7/100,000 persons for southern
Ningxia, compared with 1/100,000
persons for Yinchuan in the north
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(Table). Human AE cases were report-
ed only from the 3 southern counties
of Xiji, Haiyuan, and Guyuan; CE
cases occurred throughout Ningxia,
with a mixed endemic focus for both
human CE and AE in the south. A
variable distribution of AE and CE
cases from 1994 to 2001 was evident
from hospital records. Both AE and
CE were recorded in Xiji (6/100,000
persons), Guyuan (5/100,000 per-
sons), and Haiyuan (11/100,000 per-
sons) counties. CE incidences for
Tongxin (13/100,000 persons) and
Pengyang (5/100,000 persons) were
substantially higher than for Longde
(0.5/100,000 persons) and Jingyuan
(0.15/100,000 persons). This hetero-
geneous distribution of echinococco-
sis may reflect different patterns of
parasite transmission in different
areas of Ningxia. CE and AE inci-
dence (Table) were compared for
1994 and 2001 by chi-square test.
Apart from a substantial increase in
Haiyuan (p<0.05) and a substantial
decrease in Xiji (p<0.05), no other
substantial incidence changes were
apparent (Table).
Patients’ ages ranged from 1 to 80
years for men and from 3 to 77 years
for women (mean age 35.7 years).
The patient sex ratio was 0.72 (916
men, 1,268 women), whereas the pop-
ulation sex ratio was 1.05, indicating
significant differences in echinococ-
cosis case numbers between men and
women (p<0.05). Farm laborers
accounted for 66.1% (1,464/2,216) of
cases, students 12.4% (275/2,216),
workers and self-employed 5.2%
(116/2,216), village leaders 4.8%
(106/2,216), teachers and housewives
0.9% (21/2,216), butchers 0.2%
(4/2,216), and others 0.1%. Acompar-
ison of the ethnic composition ratio
(5) with an average incidence from
1994 to 2001 showed a substantial
difference between the Hui and Han
nationalities in Yinchuan, Haiyuan,
and Pengyang, and for Ningxia as a
whole. No substantial difference was
shown in Longde, Tongxin, Guyuan,
and Xiji for the 2 ethnic groups by
incidence risk ratios with 95% confi-
dence intervals (Table).
Radical surgery to remove CE
cysts was performed for 83.3% of
patients; only 7.3% of patients
received combined albendazole or
mebendazole chemotherapy pre- and
post-surgery. Recurrences of CE cysts
that required surgery were high
(30%), suggesting inadequate surgical
and medical care. Most AE patients
received only chemotherapy treat-
ment and were at an advanced stage of
infection.
The retrospective data of human
AE and CE infection rates in the cur-
rent study suggest that disease trans-
mission was more pronounced 10–15
years earlier. The landscape of woods
and scrub cover was greater then,
domestic sheep and dog populations
were larger, and red fox and rodent
species densities were likely higher,
providing optimal transmission condi-
tions for both Echinococcus granulo-
sus and E. multilocularis.
The incidence data (2001) for
human CE and AE are likely underes-
timated for several reasons. Access to
medical treatment for villagers is
problematic and many asymptomatic
cases (6) would be excluded. An age
and sex bias also exists, as generally
older persons and women receive
most of the limited medical attention.
Furthermore, the high surgical costs
for treatment (CE and AE), especially
in the past 10 years, coupled with
poor economic development, preclude
access to treatment in many rural
communities. Because abdominal
ultrasound examinations for CE and
AE can identify clinically silent infec-
tions (7,8), comprehensive communi-
ty-based studies are needed to identi-
fy asymptomatic or early-stage cases.
Our study provides accurate data
to determine the true prevalence and
incidence of CE and AE, which con-
tributes to better treatment outcomes.
These data can help determine the
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reasons for the heterogeneity of dis-
ease distribution in Ningxia to better
prepare for future echinococcosis
control strategies throughout the
region.
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Mycobacterium
neoaurum
Contamination 
To the Editor: In reviewing
“Rapidly Progressive Dementia due
to  Mycobacterium neoaurum
Meningoencephalitis,” by Heckman
et al. (1), I found, contrary to the
authors’ conclusion, that M. neoau-
rum was more likely a contaminant
than a cause. First, within the granulo-
matous brain lesions, the strongest
evidence for the authors’ conclusion,
no acid-fast bacilli were isolated or
identified on special stains; thus, the
Koch postulates were not satisfied.
Rather, the lesions were likely
rheumatoid nodules. Longstanding
rheumatoid arthritis commonly causes
granulomalike rheumatoid nodules. I
did a PubMed search using “rheuma-
toid nodule in the brain” and 7 articles
were found (2,3). A “rheumatoid
endarteritis” search found 25 articles.
Heckman et al. failed to exclude or
discuss this possibility. 
Second,  M. neoaurum is a rare
environmental mycobacterium that
grows in <2 days on sheep blood agar
and is not difficult to culture. As the
authors stated, there have been 8
reports of this organism, 7 isolated
from blood and 1 from urine. The
blood isolates were associated with
either central venous catheter or intra-
venous drug use. Thus, M. neoaurum
is of low virulence and unlikely to
cause spontaneous infection in tissue
unless inoculated accidentally, per-
haps. Third, polymerase chain reac-
tion (PCR) is exquisitely sensitive and
prone to contamination. The problem
is worse when bacterial DNA is
amplified by using highly conserved
primers. The PCR reagents, from the
Taq polymerase (of bacterial origin)
to water, contain sufficient, despite
minute quantity, bacterial DNA to be
amplified (4). Although direct
sequencing of the amplicon is often
blurry because of its low quantity and
mixed content, when cloned, each
amplicon may be ligated to the vector
and proliferates and gets sequenced
later.
Therefore, I believe the presence
of M. neoaurum DNA, not the organ-
ism itself, represented contamination.
Generally, drawing cause-disease
conclusion based on PCR sequencing
needs vigilance to satisfy the modi-
fied Koch postulates (5).
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